Isatin
Answer from top 10 papers
Isatin (1H-indole-2,3-dione) is a bioactive heterocyclic compound with an indole nucleus that has garnered significant interest due to its wide range of biological and pharmacological activities. These activities include, but are not limited to, antimicrobial, anticancer, anti-inflammatory, analgesic, anticonvulsant, antiviral, anti-HIV, and antiplasmodial effects (Beula et al., 2021; Cândido-Bacani et al., 2013; Hajare & Habibzadeh, 2018; Ibrahim & Elsaman, 2018; Khan & Maalik, 2015). Isatin is also an endogenous regulator that can act as a neuroprotector and modulate biochemical processes, with its effects being mediated through gene regulation and protein interactions in the brain (Medvedev & Buneeva, 2022).
Interestingly, while isatin has been shown to exhibit cytotoxic and anticancer activity against various cancer cell lines, it does not appear to have a mutagenic effect on CHO-K1 and HeLa cells at certain concentrations, instead inducing apoptosis and inhibiting cell proliferation (Severina et al., 2011). Additionally, isatin's inhibitory effects on soluble human platelet guanylate cyclase (sGC) suggest a complex interaction with the enzyme's heme binding domain, which may have implications for its pharmacological action (Charde et al., 2021).
In summary, isatin is a multifaceted compound with a broad spectrum of pharmacological properties, including significant anticancer potential. Its role as an endogenous regulator and its diverse biological activities make it a valuable subject for further research, particularly in the development of new medicinal drugs with improved potency and reduced toxicity. The non-mutagenic but apoptotic effects of isatin on certain cell lines highlight its potential for targeted therapeutic applications (Beula et al., 2021; Cândido-Bacani et al., 2013; Charde et al., 2021; Hajare & Habibzadeh, 2018; Ibrahim & Elsaman, 2018; Khan & Maalik, 2015; Medvedev & Buneeva, 2022; Severina et al., 2011).
Source Papers